KRAS status and survival in multicenter study of RAS mutations (MURAS) in patients with colorectal liver metastases receiving Y90 radioembolization treatment. This is an ASCO Meeting Abstract from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results